TO CONDUCT NON-CLINICAL GOOD LABORATORY PRACTICE (GLP) IN VIVO GENOTOXICITY AND REPRODUCTIVE TOXICOLOGY AND GLP DEVELOPMENT AND REPRODUCTIVE (DART) TOXICOLOGY STUDIES.
$3,692,037
| Recipient | ARISAN THERAPEUTICS INC UEI PYRKTQPNVJZ8 |
|---|---|
| Award ID | 75N93023C00051 |
| Award amount | $3,692,037 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — National Institutes of Health |
| NAICS | 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| PSC | AN12 |
| Set-aside | Unrestricted |
| Start date | Sep 22, 2023 |
| End date | Dec 31, 2026 |
| Place of performance | CARLSBAD, CA |
| Record updated | Sep 30, 2026 |
View the official award record
More awards won by ARISAN THERAPEUTICS INC
TO DEVELOP A THERAPEUTIC SMALL MOLECULE VIRAL ENTRY INHIBITOR AS A MEDICAL COUNTERMEASURE FOR FILOVIRUS INFECTION.
Department of Health and Human Services · $2,933,547 · Aug 3, 2026
PHASE II - SBIR TOPIC CBD192-006
Department of Defense · $1,099,662 · Sep 30, 2021
PHASE II BASE PERIOD
Department of Defense · $526,794 · Sep 28, 2021
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids